151 related articles for article (PubMed ID: 9458263)
21. The endocannabinoid system as a target for therapeutic drugs.
Piomelli D; Giuffrida A; Calignano A; Rodríguez de Fonseca F
Trends Pharmacol Sci; 2000 Jun; 21(6):218-24. PubMed ID: 10838609
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter.
Jarrahian A; Manna S; Edgemond WS; Campbell WB; Hillard CJ
J Neurochem; 2000 Jun; 74(6):2597-606. PubMed ID: 10820223
[TBL] [Abstract][Full Text] [Related]
23. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
24. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase.
Maccarrone M; Di Rienzo M; Battista N; Gasperi V; Guerrieri P; Rossi A; Finazzi-Agrò A
J Biol Chem; 2003 Sep; 278(36):33896-903. PubMed ID: 12815050
[TBL] [Abstract][Full Text] [Related]
25. Exogenous anandamide protects rat brain against acute neuronal injury in vivo.
van der Stelt M; Veldhuis WB; van Haaften GW; Fezza F; Bisogno T; Bar PR; Veldink GA; Vliegenthart JF; Di Marzo V; Nicolay K
J Neurosci; 2001 Nov; 21(22):8765-71. PubMed ID: 11698588
[TBL] [Abstract][Full Text] [Related]
26. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
27. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
[TBL] [Abstract][Full Text] [Related]
28. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
Rubino T; Viganò D; Costa B; Colleoni M; Parolaro D
J Neurochem; 2000 Dec; 75(6):2478-84. PubMed ID: 11080200
[TBL] [Abstract][Full Text] [Related]
29. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide.
Kozak KR; Prusakiewicz JJ; Rowlinson SW; Prudhomme DR; Marnett LJ
Biochemistry; 2003 Aug; 42(30):9041-9. PubMed ID: 12885237
[TBL] [Abstract][Full Text] [Related]
30. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators.
Di Marzo V
Life Sci; 1999; 65(6-7):645-55. PubMed ID: 10462065
[TBL] [Abstract][Full Text] [Related]
31. Metabolism of endocannabinoids.
Biernacki M; Skrzydlewska E
Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):830-43. PubMed ID: 27516570
[TBL] [Abstract][Full Text] [Related]
32. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
33. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053
[TBL] [Abstract][Full Text] [Related]
34. Organized trafficking of anandamide and related lipids.
Yates ML; Barker EL
Vitam Horm; 2009; 81():25-53. PubMed ID: 19647107
[TBL] [Abstract][Full Text] [Related]
35. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.
Vogel Z; Barg J; Levy R; Saya D; Heldman E; Mechoulam R
J Neurochem; 1993 Jul; 61(1):352-5. PubMed ID: 8515284
[TBL] [Abstract][Full Text] [Related]
36. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine.
Sugiura T; Kondo S; Sukagawa A; Tonegawa T; Nakane S; Yamashita A; Ishima Y; Waku K
Eur J Biochem; 1996 Aug; 240(1):53-62. PubMed ID: 8797835
[TBL] [Abstract][Full Text] [Related]
37. Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor.
Hampson AJ; Hill WA; Zan-Phillips M; Makriyannis A; Leung E; Eglen RM; Bornheim LM
Biochim Biophys Acta; 1995 Nov; 1259(2):173-9. PubMed ID: 7488638
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
Veldhuis WB; van der Stelt M; Wadman MW; van Zadelhoff G; Maccarrone M; Fezza F; Veldink GA; Vliegenthart JF; Bär PR; Nicolay K; Di Marzo V
J Neurosci; 2003 May; 23(10):4127-33. PubMed ID: 12764100
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.
Hillard CJ; Edgemond WS; Jarrahian A; Campbell WB
J Neurochem; 1997 Aug; 69(2):631-8. PubMed ID: 9231721
[TBL] [Abstract][Full Text] [Related]
40. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.
Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
